{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T01:10:27Z","timestamp":1779153027973,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>\n                      Estrogen receptors (ER) are implicated in psychiatric disorders. We assessed if ER availability in the human brain could be quantified using 16\u03b1-[\n                      <jats:sup>18<\/jats:sup>\n                      F]-fluoro-17\u03b2-estradiol ([\n                      <jats:sup>18<\/jats:sup>\n                      F]FES) positron emission tomography (PET).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Procedures<\/jats:title>\n                    <jats:p>\n                      Seven post\u2011menopausal women underwent a dynamic [\n                      <jats:sup>18<\/jats:sup>\n                      F]FES PET scan with arterial blood sampling. A T1-weighted MRI was acquired for anatomical information. After one week, four subjects received a selective ER degrader (SERD), four hours before the PET scan. Pharmacokinetic analysis was performed using a metabolite-corrected plasma curve as the input function. The optimal kinetic model was selected based on the Akaike information criterion and standard error of estimated parameters. Accuracy of Logan graphical analysis and standardized uptake value (SUV) was determined via correlational analyses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The reversible two-tissue compartment model (2T4k) model with fixed K\n                      <jats:sub>1<\/jats:sub>\n                      \/k\n                      <jats:sub>2<\/jats:sub>\n                      was preferred. The total volume of distribution (V\n                      <jats:sub>T<\/jats:sub>\n                      ) could be more reliably estimated than the binding potential (BP\n                      <jats:sub>ND<\/jats:sub>\n                      ). A high correlation of V\n                      <jats:sub>T<\/jats:sub>\n                      with Logan graphical analysis was observed, but only a moderate correlation with SUV. SERD administration resulted in a reduced V\n                      <jats:sub>T<\/jats:sub>\n                      in the pituitary gland, but not in other regions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The optimal quantification method for [\n                      <jats:sup>18<\/jats:sup>\n                      F]FES was the 2T4k with fixed K\n                      <jats:sub>1<\/jats:sub>\n                      \/k\n                      <jats:sub>2<\/jats:sub>\n                      or Logan graphical analysis, but specific binding was only observed in the pituitary gland.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11307-023-01880-z","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T14:02:22Z","timestamp":1706018542000},"page":"351-359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacokinetic Analysis of [18F]FES PET in the Human Brain and Pituitary Gland"],"prefix":"10.1007","volume":"26","author":[{"given":"Nafiseh","family":"Ghazanfari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2925-9959","authenticated-orcid":false,"given":"Janine","family":"Doorduin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris W. J.","family":"van der Weijden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoon T. M.","family":"Willemsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andor W. J. M.","family":"Glaudemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aren","family":"van Waarde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudi A. J. O.","family":"Dierckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik F. J.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"key":"1880_CR1","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S0306-4530(98)00071-7","volume":"23","author":"E Baulieu","year":"1998","unstructured":"Baulieu E (1998) Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23:963\u2013987","journal-title":"Psychoneuroendocrinology"},{"key":"1880_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/ijms22010373","volume":"22","author":"WJ Hwang","year":"2020","unstructured":"Hwang WJ, Lee TY, Kim NS, Kwon JS (2020) The role of estrogen receptors and their signaling across psychiatric disorders. Int J Mol Sci 22:373","journal-title":"Int J Mol Sci"},{"key":"1880_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.yhbeh.2015.04.018","volume":"74","author":"AC McCarrey","year":"2015","unstructured":"McCarrey AC, Resnick SM (2015) Postmenopausal hormone therapy and cognition. Horm Behav 74:167\u2013172","journal-title":"Horm Behav"},{"key":"1880_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/978-3-030-53176-8_14","volume-title":"PET and SPECT of neurobiological systems","author":"R Moraga-Amaro","year":"2021","unstructured":"Moraga-Amaro R, Doorduin J, Dierckx RA, de Vries EF (2021) PET and SPECT imaging of steroid hormone receptors in the brain. In: Dierckx RA, Otte A, de Vries EF, van Waarde A, Lammertsma AA (eds) PET and SPECT of neurobiological systems. Springer, Cham, pp 483\u2013520"},{"key":"1880_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2967\/jnumed.111.092734","volume":"53","author":"M van Kruchten","year":"2012","unstructured":"van Kruchten M, Glaudemans AW, de Vries EF et al (2012) PET imaging of estrogen receptors as a diagnostic tool for breast cancer patients presenting with a clinical dilemma. J Nucl Med 53:182\u2013190","journal-title":"J Nucl Med"},{"key":"1880_CR6","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/S1470-2045(18)30936-7","volume":"20","author":"SY Chae","year":"2019","unstructured":"Chae SY, Ahn SH, Kim S-B et al (2019) Diagnostic accuracy and safety of 16\u03b1-[18F] fluoro-17\u03b2-oestradiol PET-CT for the assessment of oestrogen receptor status in recurrent or metastatic lesions in patients with breast cancer: a prospective cohort study. Lancet Oncol 20:546\u2013555","journal-title":"Lancet Oncol"},{"key":"1880_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2967\/jnumed.113.128751","volume":"55","author":"MA Khayum","year":"2014","unstructured":"Khayum MA, de Vries EF, Glaudemans AW et al (2014) In vivo imaging of brain estrogen receptors in rats: a 16\u03b1-18F-fluoro-17\u03b2-estradiol PET study. J Nucl Med 55:481\u2013487","journal-title":"J Nucl Med"},{"key":"1880_CR8","first-page":"694","volume":"63","author":"R Iqbal","year":"2022","unstructured":"Iqbal R, Yaqub M, Oprea-Lager DE et al (2022) Biodistribution of 18F-FES in patients with metastatic ER+ breast cancer undergoing treatment with Rintodestrant (G1T48), a novel selective estrogen receptor degrader. J Nucl Med 63:694\u2013699","journal-title":"J Nucl Med"},{"key":"1880_CR9","first-page":"679","volume":"42","author":"DA Mankoff","year":"2001","unstructured":"Mankoff DA, Peterson LM, Tewson TJ et al (2001) [18F] fluoroestradiol radiation dosimetry in human PET studies. J Nucl Med 42:679\u2013684","journal-title":"J Nucl Med"},{"key":"1880_CR10","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s13318-020-00635-3","volume":"45","author":"MG Conlan","year":"2020","unstructured":"Conlan MG, de Vries EF, Glaudemans A et al (2020) Pharmacokinetic and pharmacodynamic studies of elacestrant, a novel oral selective estrogen receptor degrader, in healthy post-menopausal women. Eur J Drug Metab Pharmacokinet 45:675\u2013689","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"1880_CR11","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1097\/CAD.0000000000000271","volume":"26","author":"F Garner","year":"2015","unstructured":"Garner F, Shomali M, Paquin D et al (2015) RAD1901: a novel, orally bioavailable selective estrogen receptor degrader that demonstrates antitumor activity in breast cancer xenograft models. Anticancer Drugs 26:948\u2013956","journal-title":"Anticancer Drugs"},{"key":"1880_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41523-022-00497-9","volume":"8","author":"GR Hancock","year":"2022","unstructured":"Hancock GR, Young KS, Hosfield DJ et al (2022) Unconventional isoquinoline-based SERMs elicit fulvestrant-like transcriptional programs in ER+ breast cancer cells. NPJ Breast Cancer 8:130\u2013156","journal-title":"NPJ Breast Cancer"},{"key":"1880_CR13","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.neuroimage.2005.02.018","volume":"26","author":"J Ashburner","year":"2005","unstructured":"Ashburner J, Friston KJ (2005) Unified segmentation. Neuroimage 26:839\u2013851","journal-title":"Neuroimage"},{"key":"1880_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/hbm.10123","volume":"19","author":"A Hammers","year":"2003","unstructured":"Hammers A, Allom R, Koepp MJ et al (2003) Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp 19:224\u2013247","journal-title":"Hum Brain Mapp"},{"key":"1880_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/brain\/113.1.27","volume":"113","author":"K Leenders","year":"1990","unstructured":"Leenders K, Perani D, Lammertsma A et al (1990) Cerebral blood flow, blood volume and oxygen utilization: normal values and effect of age. Brain 113:27\u201347","journal-title":"Brain"},{"key":"1880_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/jcbfm.2009.190","volume":"30","author":"VJ Cunningham","year":"2010","unstructured":"Cunningham VJ, Rabiner EA, Slifstein M et al (2010) Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited. J Cereb Blood Flow Metab 30:46\u201350","journal-title":"J Cereb Blood Flow Metab"},{"key":"1880_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroimage.2004.09.043","volume":"24","author":"E Rostrup","year":"2005","unstructured":"Rostrup E, Knudsen GM, Law I et al (2005) The relationship between cerebral blood flow and volume in humans. Neuroimage 24:1\u201311","journal-title":"Neuroimage"},{"key":"1880_CR18","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0969-8051(00)00137-2","volume":"27","author":"J Logan","year":"2000","unstructured":"Logan J (2000) Graphical analysis of PET data applied to reversible and irreversible tracers. Nucl Med Biol 27:661\u2013670","journal-title":"Nucl Med Biol"},{"key":"1880_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/cne.901510204","volume":"151","author":"D Pfaff","year":"1973","unstructured":"Pfaff D, Keiner M (1973) Atlas of estradiol-concentrating cells in the central nervous system of the female rat. J Comp Neurol 151:121\u2013158","journal-title":"J Comp Neurol"},{"key":"1880_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/cne.901700302","volume":"170","author":"DW Pfaff","year":"1976","unstructured":"Pfaff DW, Gerlach JL, McEwen BS et al (1976) (1976) Autoradiographic localization of hormone-concentrating cells in the brain of the female rhesus monkey. J Comp Neurol 170:279\u2013293","journal-title":"J Comp Neurol"},{"key":"1880_CR21","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s11307-020-01520-w","volume":"22","author":"M Paquette","year":"2020","unstructured":"Paquette M, Phoenix S, Lavall\u00e9e \u00c9 et al (2020) Cross-species physiological assessment of brain estrogen receptor expression using 18 F-FES and 18 F-4FMFES PET imaging. Mol Imaging Biol 22:1403\u20131413","journal-title":"Mol Imaging Biol"},{"key":"1880_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000338397","volume":"96","author":"RJ Handa","year":"2012","unstructured":"Handa RJ, Mani SK, Uht RM (2012) Estrogen receptors and the regulation of neural stress responses. Neuroendocrinology 96:111\u2013118","journal-title":"Neuroendocrinology"},{"key":"1880_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41386-018-0167-9","volume":"44","author":"AL Heck","year":"2019","unstructured":"Heck AL, Handa RJ (2019) Sex differences in the hypothalamic\u2013pituitary\u2013adrenal axis\u2019 response to stress: an important role for gonadal hormones. Neuropsychopharmacology 44:45\u201358","journal-title":"Neuropsychopharmacology"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-023-01880-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-023-01880-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-023-01880-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T12:20:13Z","timestamp":1711542013000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-023-01880-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1880"],"URL":"https:\/\/doi.org\/10.1007\/s11307-023-01880-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2881396\/v1","asserted-by":"object"}]},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,23]]},"assertion":[{"value":"1 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standard.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This study was financially supported by Radius Health, Inc. Institutional financial support for contracted research beyond the scope of this work was obtained from GE Healthcare, Hoffmann-La Roche, GlaxoSmithKline, Ionis Pharmaceuticals, Janssen-Cilag, and Bristol Myers Squibb. No other potential conflicts of interest relevant to this article exist.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}